All In Biotech

Free tool

FAERS Monitor: Vybrique

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 210858 or its brand name (Vybrique, Sildenafil Citrate). Reports on generic versions are filed under their own applications.

Reports

58,697

Serious

42,844

73% of reports

Hospitalization

25,676

Death reported

8,676

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • dyspnoea8,090
  • headache6,073
  • diarrhoea4,714
  • nausea4,199
  • fatigue4,055
  • death4,027
  • dizziness3,520
  • drug ineffective3,249
  • cough3,224
  • pneumonia2,743
  • hypotension2,493
  • vomiting2,491
  • off label use2,399
  • malaise2,253
  • pain2,116

Reports by year received

View as table
YearReports
2004124
2005186
2006393
2007174
2008234
2009295
2010416
2011457
20121,172
20131,589
20142,307
20152,706
20163,100
20173,839
20184,222
20195,480
20205,142
20214,407
20224,449
20234,803
20244,904
20255,073
20263,225

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,995,462 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
dyspnoeaSignal8,0905.25.127,643
hypotensionSignal2,4934.54.36,756
coughSignal3,2244.24.07,737
headacheSignal6,0733.53.411,039
pneumoniaSignal2,7433.12.93,812
diarrhoeaSignal4,7142.62.64,870
dizzinessSignal3,5202.52.53,340
nausea4,1991.91.91,868
vomiting2,4911.91.81,086
fatigue4,0551.91.81,697
malaise2,2531.81.8885
death4,0271.71.61,145
pain2,1161.21.297
off label use2,3991.00.91
drug ineffective3,2490.90.953

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.